18 February 2013 | News | By BioSpectrum Bureau
Hong Kong-based Zuellig Pharma Specialty to dispose its 51 percent stake in Metronic I-Care (MiCare) to Malaysia-based Metronic for $3.29 million
Singapore: Hong Kong-based Zuellig Pharma Specialty has entered into a sale and purchase agreement with Malaysia-based Metronic Global. According to the agreement, Zuellig will dispose its 51 percent stake in Metronic I-Care (MiCare) for $3.29 million (RM10.19 million).
In its filling to Bursa Malaysia, Metronic highlighted that the sale and purchase agreement involves the sale of its 1,379,051 ordinary shares in MiCare. A circular and notice of extraordinary general meeting, setting out the full details of the disposal, will soon be dispatched to the shareholders of Metronic.